Rytelo

Active Ingredient(s): Imetelstat Sodium
FDA Approved: * June 6, 2024
Pharm Company: * GERON
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Rytelo 188 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 82959-111
Labeler:
Geron Corporation
Rytelo 47 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 82959-112
Labeler:
Geron Corporation